Cholesterol drug showdown: one pill or two for your heart?
NCT ID NCT07313124
First seen Jan 09, 2026 · Last updated May 16, 2026 · Updated 16 times
Summary
This study looked at whether taking two cholesterol-lowering drugs together works better and is safer than taking just one. 66 adults with heart disease and high cholesterol were given either a single drug (rosuvastatin) or a combination (rosuvastatin plus ezetimibe) for 12 weeks. Researchers measured cholesterol levels and checked for muscle and liver side effects to find the best approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES (CVD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beni-Suef University Hospital
Banī Suwayf, Beni Suweif Governorate, 62521, Egypt
Conditions
Explore the condition pages connected to this study.